MIRA
MIRA PHAR (MIRA)
NASDAQ
$0.95-$0.009 (-0.94%)
Price as of Jun 23, 2026 7:27 PM EDT
  • $40.0M
    Market Cap
  • -18.33%
    1-Year Change
  • Drug Manufacturers - General
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
63,699
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
63,699
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
0
-100.00%
102,000
N/A
Research and Development Expense
-1.7M
-47.97%
-3.3M
+110.15%
-1.6M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
10.5M
+30.86%
8.0M
-5.95%
8.5M
N/A
Operating Profit
N/A
N/A
N/A
N/A
-12.0M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-165,669
-95.21%
-3.5M
N/A
Interest Income and Expense and Net
0
+100.00%
-165,669
-95.21%
-3.5M
N/A
Total Nonoperating Income and Expense
50,627
+130.56%
-165,669
-104.79%
3.5M
N/A
Income before Taxes
-32.0M
N/A
N/A
N/A
-12.0M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-32.0M
N/A
N/A
N/A
-12.0M
N/A
Net Income from Continuing Operations Applicable to Common
-32.0M
N/A
N/A
N/A
-12.0M
N/A
Basic EPS and Net Income
-1.35
+164.71%
-0.51
-20.31%
-0.64
N/A
Diluted EPS and Net Income
-1.35
+164.71%
-0.51
-20.31%
-0.64
N/A
Basic Weighted Average Shares
23.7M
+53.42%
15.4M
-16.82%
18.6M
N/A
Diluted Weighted Average Shares
23.7M
+53.42%
15.4M
-16.82%
18.6M
N/A
Balance Sheet
Cash and Cash Equivalents
6.3M
+26.94%
5.0M
+8.64%
4.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.3M
+26.94%
5.0M
+8.64%
4.6M
N/A
Total Current Assets
11.1M
+282.95%
2.9M
-40.56%
4.9M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
3.5M
-7.89%
3.8M
N/A
Total Assets
11.1M
+279.52%
2.9M
-40.74%
4.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
702,068
-2.94%
723,349
+29.61%
558,097
N/A
Total Long-Term Debt
N/A
N/A
3.0M
0.00%
3.0M
N/A
Total Long-Term Liabilities
N/A
N/A
4.8M
-0.11%
4.8M
N/A
Total Liabilities
702,068
-2.94%
723,349
+29.61%
558,097
N/A
Retained Earnings
-39.6M
+35.84%
-29.1M
+36.89%
-21.3M
N/A
Total Stockholders Equity
10.4M
+372.40%
2.2M
-49.71%
4.4M
N/A
Total Shares Outstanding
41.9M
+153.24%
16.6M
+12.04%
14.8M
N/A
Cash Flow
Cash from Operating Activities
-4.7M
-16.17%
-5.6M
+22.69%
-4.5M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
8.2M
+115.66%
3.8M
-56.84%
8.8M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-456.59%
N/A
N/A
N/A
N/A
N/A
Return on Equity
-508.28%
N/A
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
15.75
+294.55%
3.99
N/A
N/A
N/A
Cash Ratio
9.04
+30.79%
6.91
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow